Search research articles
Contact Us
Filters
Showing results (181-190 of 210) with videos related to
Page
of 21
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Haematologica
|
August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
Ruben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.
Blood
|
March 5, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis
Barbara Mora, Francesca Palandri, Paola Guglielmelli, et al.
Blood
|
August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
The Journal of Allergy and Clinical Immunology
|
April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
Cem Akin, Vito Sabato, Jason Gotlib, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Cell Stem Cell
|
January 22, 2013
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition
Daniel J Goff, Angela Court Recart, Anil Sadarangani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
David Fuchs, Alex Kilbertus, Karin Kofler, et al.
Blood Advances
|
January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
Jason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 210) with videos related to
Sort By:
Page
of 21
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Haematologica
|
August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
Ruben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.
Blood
|
March 5, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis
Barbara Mora, Francesca Palandri, Paola Guglielmelli, et al.
Blood
|
August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
The Journal of Allergy and Clinical Immunology
|
April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
Cem Akin, Vito Sabato, Jason Gotlib, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Cell Stem Cell
|
January 22, 2013
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition
Daniel J Goff, Angela Court Recart, Anil Sadarangani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
David Fuchs, Alex Kilbertus, Karin Kofler, et al.
Blood Advances
|
January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
Jason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Page
of 21